What Is a Monoclonal Antibody?
·4 min read
Learn what a monoclonal antibody is, why it matters in biotech, and how antibody drugs shape development, approval, and market competition.
Blog Category
Biotech Basics
Core biotech concepts and drug modalities — catalysts, partnerships, financing, patent cliffs, small molecules, antibodies, and what makes a drug differentiated.
What Is a Small Molecule?
·4 min read
Learn what a small molecule drug is, why it matters in biotech, and how small molecules differ from biologics and other therapies.
What Does MOA Mean in Biotech News?
·4 min read
Learn what MOA means in biotech, why mechanism of action matters, and how it helps investors interpret drug development and news.
What Is a Patent Cliff and Why Do Investors Care So Much?
·4 min read
Learn what a patent cliff is, why it matters for biotech and pharma revenue, and how expiration risk affects stock valuations.
What Is a Biosimilar and Why Does It Matter for Biotech Investors?
·4 min read
Learn what a biosimilar is, why it matters for biologic competition, and how biosimilar news can affect original drug markets.
What Is a Best-in-Class Drug?
·4 min read
Learn what best-in-class means in biotech, why it matters for competition and commercial value, and how investors judge the claim.
What Is a First-in-Class Drug?
·4 min read
Learn what first-in-class means in biotech, why it matters for drug innovation, and how investors use the term to judge novelty and risk.
Why Biotech Is Especially Well-Suited to Event-Driven Information Products
·4 min read
Learn why biotech is naturally suited to event-driven news products, and why catalysts, timelines, and regulatory milestones create strong product value.
What Does "Catalyst" Mean in Biotech News?
·5 min read
Learn what a catalyst means in biotech news, why catalyst events move stocks, and how investors use catalyst alerts to track trials and FDA milestones.
Why Financing News Matters So Much in Biotech
·4 min read
Learn why biotech financing news moves stocks, how dilution risk affects catalysts, and why capital raises shape future event timing.
Why Partnership Announcements Often Matter So Much in Biotech
·4 min read
Learn why biotech partnership announcements are important catalysts and how they affect funding, validation, commercialization, and sentiment.
What News Matters Before and After Drug Commercialization?
·4 min read
Learn which biotech news matters most before and after commercialization, from launch preparation and approval to sales updates and market access.
What Is a Catalyst Window? Why Timing Matters in Biotech Alerts
·4 min read
Learn what a catalyst window is, why timing matters in biotech news, and how investors use windows to monitor trial, FDA, and earnings events.
Why Biotech News Clusters Around Key Dates
·5 min read
Learn why biotech news clusters around trial timelines, FDA dates, conferences, and earnings, and how investors use those windows to monitor catalysts.
Biotech Company Earnings: What Investors Should Watch Before the Call
·4 min read
Learn which signals matter before biotech earnings, including pipeline updates, cash runway, guidance, catalyst timing, and regulatory clues.
What Is a Biotech Catalyst? Why It Matters in Biotech News
·7 min read
Learn what a biotech catalyst is, why catalyst-driven news moves biotech stocks, and how investors use catalyst alerts to follow FDA and clinical events.